Pathways to Access and Reimbursement

As PMPRB modernization and the shift towards affordability are finalized, manufacturers must be more agile than ever. The Pathways to Access and Reimbursement (formerly Pharma Symposium) will provide a setting for strategic discussion among industry stakeholders about their expectations moving forward:

• What will the impact of the PMPRB Guidelines Review?
• How is the regulatory landscape shifting in pharma?
• How can patient maintain access to the drugs they need?
• What can Canada learn from international examples of access and reimbursement regimes?